# TScan Therapeutics

a clinical-stage biotechnology company building a TCR discovery and TCR-T treatment platform, reporting first-quarter 2026 financials in May 2026; it identifies tumour-specific targets via T-cell receptor sequencing.

Source: https://en.bioecon.ru/companies/tscan-therapeutics/
Updated: 2026-07-11

- Country: United States
- Ticker: TCRX

## Technologies

- [TCR therapy (T-cell receptor engineered T cells)](https://en.bioecon.ru/technology/tcr-therapy/)